Article Information
History
- October 3, 2021.
Article Versions
- Version 1 (June 13, 2021 - 16:27).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Zena Lapp, PhD1,2,
- Jennifer H Han, MD3,
- Divya Choudhary, BTech4,
- Stuart Castaneda, MS1,
- Ali Pirani, MS5,
- Kevin Alby, PhD6,
- Pam C Tolomeo, MPH, CCRP7,
- Ellie JC Goldstein, MD8,
- Ebbing Lautenbach, MD9 and
- Evan S Snitkin, PhD5,10,*
- 1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109
- 2Duke Global Health Institute, Duke University, Durham, NC 27710
- 3GlaxoSmithKline, Rockville, MD 20850
- 4Department of Biochemistry, University of Oxford, Oxford, United Kingdom OX2 6HD
- 5Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan 48109
- 6University of North Carolina, Chapel Hill, NC 27599
- 7Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104
- 8R M Alden Research Laboratory; David Geffen School of Medicine, University of California, Los Angeles, Santa Monica, CA 90404
- 9Department of Medicine (Infectious Diseases), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104
- 10Department of Internal Medicine/Division of Infectious Diseases, University of Michigan, Ann Arbor, MI 48109
- ↵*Corresponding author
Evan Snitkin, 1520D MSRB I, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109-5680, (734) 647-6472, esnitkin{at}umich.edu
Author Contributions E.S.S., J.H.H., E.L., and Z.L. conceptualized the study and acquired funding to support the project. K.A. performed MIC testing. Z.L, A.P., S.C., and D.C. performed data curation and formal analysis. Z.L. performed investigation and visualization. E.S.S. and Z.L. developed methodology. E.S.S. supervised the project. Z.L. and E.S.S. wrote the original draft. All authors reviewed and edited the manuscript.
Posted October 03, 2021.
Fitness barriers to spread of colistin resistance overcome by first establishing niche in patients with enhanced colistin exposure
